ResMed
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.About RMD
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases.
RMD Key Statistics
Stock Snapshot
With a market cap of 38.31B, ResMed(RMD) trades at $263.03. The stock has a price-to-earnings ratio of 26.00 and currently yields dividends of 85.9%.
During the trading session on 2026-02-05, ResMed(RMD) shares reached a daily high of $264.88 and a low of $252.42. At a current price of $263.03, the stock is +4.2% higher than the low and still -0.7% under the high.
Trading volume for ResMed(RMD) stock has reached 1.73M, versus its average volume of 1.33M.
The stock's 52-week range extends from a low of $199.92 to a high of $293.81.
The stock's 52-week range extends from a low of $199.92 to a high of $293.81.
RMD News
ResMed (NYSE:RMD) is expanding its digital health ecosystem around sleep apnea diagnosis and treatment, supported by tools such as myAir, AirView, and Brightree...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement. ResMed Inc. has reported an increase in the n...
ResMed (NYSE:RMD) is at an inflection point as wearable devices move into mainstream use for sleep apnea screening. Recent FDA approvals support broader adopti...
Analyst ratings
69%
of 29 ratingsMore RMD News
...
Advertisement What ResMed’s latest quarter means for shareholders ResMed (RMD) has drawn fresh attention after fiscal second quarter results topped market exp...
Citi analyst Laura Sutcliffe raised the firm’s price target on ResMed (RMD) to $345 from $330 and keeps a Buy rating on the shares. Published first on TheFly –...
In late January 2026, ResMed reported past fiscal second-quarter results showing sales of US$1,422.81 million and net income of US$392.59 million, alongside a U...
Resmed Inc (RMD) has disclosed a new risk, in the Regulation category. Resmed Inc. continues to face the same material risks and uncertainties previously discl...
Resmed Inc ((RMD)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and p...
On Thursday, ResMed Inc (NYSE:RMD) reported that second-quarter fiscal 2026 adjusted earnings of 2.81, beating the consensus of $2.72. Quarterly sales increase...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.